Serina Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| WEST MICHAEL D | Chief Executive Officer | Option Exercise | 3,125 | — | — | 39,652 | Dec 11, 2021 |
| WEST MICHAEL D | Chief Executive Officer | Option Exercise | 3,125 | — | — | 37,608 | Sep 11, 2021 |
| WEST MICHAEL D | Chief Executive Officer | Option Exercise | 3,125 | — | — | 35,564 | Jun 11, 2021 |
| WEST MICHAEL D | Chief Executive Officer | Option Exercise | 3,125 | — | — | 33,723 | Mar 11, 2021 |
| WEST MICHAEL D | Chief Executive Officer | Tax Withholding | 1,081 | $1.69 | $1,827 | 30,598 | Dec 11, 2020 |
| WEST MICHAEL D | Chief Executive Officer | Option Exercise | 3,125 | — | — | 29,635 | Sep 11, 2020 |
| WEST MICHAEL D | Chief Executive Officer | Option Exercise | 3,125 | — | — | 27,591 | Jun 11, 2020 |
| WEST MICHAEL D | Chief Executive Officer | Tax Withholding | 5,085 | $0.88 | $4,475 | 24,446 | Mar 11, 2020 |
| Juvenescence Ltd | — | Purchase | 19,000 | — | — | 16,419,000 | Aug 13, 2019 |
| WEST MICHAEL D | Chief Executive Officer | Purchase | 4,000 | $3.86 | $15,440 | 15,460 | Dec 10, 2018 |